Phase 2 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have received a stem cell transplant from a related or unrelated donor.
- Adults aged 18 to 45 years old at the time of vaccination.
- People who received an HPV vaccine before their transplant may still be considered for inclusion.
Who may not be able to join:
- People with a very low platelet count (below 50 x 10⁹/L) that makes injections into the muscle unsafe.
- People experiencing severe acute graft-versus-host disease (a serious complication after transplant) rated at grade III or IV (confirm with trial site).
- People with extensive long-term graft-versus-host disease that requires high-dose steroid treatment plus at least two other ongoing treatments for that condition (confirm with trial site).
- People taking prednisone (a steroid medication) at doses above 1mg per kilogram of body weight per day at the time the study begins.
- People who received rituximab (a medication that affects the immune system) within the 6 months before vaccination is due to start.
- People who received intravenous or injectable immunoglobulin treatment within 3 months before vaccination is due to start.
- People who are pregnant, wish to become pregnant, or are actively trying to conceive during the vaccination period and for up to three months after the last vaccine dose.
- People taking blood-thinning medications that make muscle injections unsafe.
- People with a known allergy to Gardasil 9 (the HPV vaccine being used in this trial).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0046313427358
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary outcome - GMT level against HPV 16
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.